Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Levodopa-induced Dyskinesia”

71 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 71 results

Not applicableUnknownNCT04173845
What this trial is testing

Double Randomized and Placebo Controlled Trail of Tianqi Pingchan Granule to Prevent Levodopa-Induced Dyskinesia

Who this might be right for
Levodopa-Induced Dyskinesia
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 150
Testing effectiveness (Phase 2)Study completedNCT00314288
What this trial is testing

Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia

Who this might be right for
Parkinson's DiseaseDyskinesia
EMD Serono 360
Testing effectiveness (Phase 2)Study completedNCT03368170
What this trial is testing

Efficacy and Tolerability of IRL790 in Parkinson's Disease Dyskinesia

Who this might be right for
Parkinson Disease
Integrative Research Laboratories AB 75
Early research (Phase 1)UnknownNCT06021756
What this trial is testing

Phase I Open-label Study of Low-dose Ketamine Infusion Treatment in Levodopa-Induced Dyskinesia in Parkinson's Disease

Who this might be right for
Levodopa-Induced DyskinesiaParkinson's Disease
University of Arizona 9
Not applicableUnknownNCT05795088
What this trial is testing

Continuous Theta Burst Stimulation as Potential Biomarker of Levodopa-induced Dyskinesias in Parkinson's Disease

Who this might be right for
Parkinson Disease
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 60
Testing effectiveness (Phase 2)Study completedNCT00076674
What this trial is testing

Levetiracetam Treatment of L-dopa Induced Dyskinesias

Who this might be right for
DyskinesiasParkinson Disease
National Institute of Neurological Disorders and Stroke (NINDS) 40
Testing effectiveness (Phase 2)Study completedNCT04435431
What this trial is testing

A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia

Who this might be right for
Parkinson Disease
Integrative Research Laboratories AB 155
Testing effectiveness (Phase 2)Ended earlyNCT00607451
What this trial is testing

Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia

Who this might be right for
Levodopa-induced Dyskinesia
Neurim Pharmaceuticals Ltd. 8
Testing effectiveness (Phase 2)Ended earlyNCT03922711
What this trial is testing

Assess the Safety and Effectiveness of Pridopidine Compared to Placebo in the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease

Who this might be right for
Parkinson Disease
Prilenia 23
Testing effectiveness (Phase 2)WithdrawnNCT00758368
What this trial is testing

Comparison of Continuous and Pulsatile Apomorphine in Parkinson's Disease

Who this might be right for
Parkinson's Disease
Oregon Health and Science University
Testing effectiveness (Phase 2)Study completedNCT01491529
What this trial is testing

Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Who this might be right for
DyskinesiasParkinson DiseaseMovement Disorders+2 more
Novartis Pharmaceuticals 154
Testing effectiveness (Phase 2)Study completedNCT00036296
What this trial is testing

Effects of Talampanel on Patients With Advanced Parkinson's Disease

Who this might be right for
DyskinesiasParkinson DiseaseMovement Disorders
Teva Branded Pharmaceutical Products R&D, Inc. 22
Testing effectiveness (Phase 2)Study completedNCT00582673
What this trial is testing

Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients, and Safety in Combination With L-dopa

Who this might be right for
Parkinson's Disease
Novartis 31
Testing effectiveness (Phase 2)Study completedNCT05148884
What this trial is testing

Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia

Who this might be right for
Medication-Induced Dyskinesia
Neurolixis SAS 27
Not applicableStudy completedNCT01429207
What this trial is testing

Capturing Parkinson's Disease Medication Side Effects During Daily Activities

Who this might be right for
Parkinson's DiseaseDyskinesia
Great Lakes NeuroTechnologies Inc. 15
Not applicableStudy completedNCT04064294
What this trial is testing

Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-Induced
VA Office of Research and Development 93
Large-scale testing (Phase 3)Study completedNCT02274766
What this trial is testing

Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia

Who this might be right for
DyskinesiaLevodopa-Induced Dyskinesia (LID)Parkinson's Disease (PD)
Adamas Pharmaceuticals, Inc. 77
Testing effectiveness (Phase 2)Study completedNCT01937078
What this trial is testing

Famotidine for Levodopa-induced Dyskinesia in PD

Who this might be right for
Dyskinesia
University Health Network, Toronto 7
Large-scale testing (Phase 3)Ended earlyNCT02153645
What this trial is testing

Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.

Who this might be right for
Parkinson's DiseaseLevodopa Induced Dyskinesias (LID)
Adamas Pharmaceuticals, Inc. 87
Testing effectiveness (Phase 2)Study completedNCT01385592
What this trial is testing

Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Who this might be right for
DyskinesiasParkinson DiseaseMovement Disorders+1 more
Novartis Pharmaceuticals 78
Load More Results